1SEJ
Crystal Structure of Dihydrofolate Reductase-Thymidylate Synthase from Cryptosporidium hominis Bound to 1843U89/NADPH/dUMP
Summary for 1SEJ
Entry DOI | 10.2210/pdb1sej/pdb |
Related | 1qzf |
Descriptor | bifunctional dihydrofolate reductase-thymidylate synthase, 2'-DEOXYURIDINE 5'-MONOPHOSPHATE, S)-2-(5(((1,2-DIHYDRO-3-METHYL-1-OXOBENZO(F)QUINAZOLIN-9-YL)METHYL)AMINO)1-OXO-2-ISOINDOLINYL)GLUTARIC ACID, ... (5 entities in total) |
Functional Keywords | bifunctional enzyme, transferase, oxidoreductase |
Biological source | Cryptosporidium hominis |
Total number of polymer chains | 5 |
Total formula weight | 311585.64 |
Authors | Anderson, A.C. (deposition date: 2004-02-17, release date: 2004-05-18, Last modification date: 2023-08-23) |
Primary citation | Anderson, A.C. Two crystal structures of dihydrofolate reductase-thymidylate synthase from Cryptosporidium hominis reveal protein-ligand interactions including a structural basis for observed antifolate resistance. Acta Crystallogr.,Sect.F, 61:258-262, 2005 Cited by PubMed Abstract: Cryptosporidium hominis is a protozoan parasite that causes acute gastrointestinal illness. There are no effective therapies for cryptosporidiosis, highlighting the need for new drug-lead discovery. An analysis of the protein-ligand interactions in two crystal structures of dihydrofolate reductase-thymidylate synthase (DHFR-TS) from C. hominis, determined at 2.8 and 2.87 A resolution, reveals that the interactions of residues Ile29, Thr58 and Cys113 in the active site of C. hominis DHFR provide a possible structural basis for the observed antifolate resistance. A comparison with the structure of human DHFR reveals active-site differences that may be exploited for the design of species-selective inhibitors. PubMed: 16511011DOI: 10.1107/S1744309105002435 PDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (2.87 Å) |
Structure validation
Download full validation report